Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Why we need new classification models in meningioma management.

Literature DB >> 35067786

Why we need new classification models in meningioma management.

Marco V Corniola^1,2,3,4.

Abstract

Entities: Chemical

Mesh：

Year: 2022 PMID： 35067786 DOI： 10.1007/s00701-022-05127-8

Source DB: PubMed Journal: Acta Neurochir (Wien) ISSN： 0001-6268 Impact factor: 2.216

× No keyword cloud information.

16 in total

1. Pyrosequencing Analysis of MGMT Promoter Methylation in Meningioma.

Authors: Ioannis Panagopoulos; Ludmila Gorunova; Henning Leske; Pitt Niehusmann; Lene E Johannessen; Julie Staurseth; Nina Øino; Torstein R Meling; Sverre Heim; Francesca Micci; Petter Brandal
Journal: Cancer Genomics Proteomics Date: 2018 Sep-Oct Impact factor: 4.069

2. WHO grade I meningiomas: classification-tree for prognostic factors of survival.

Authors: Jean-Michel Lemée; Holger Joswig; Michele Da Broi; Marco Vincenzo Corniola; David Scheie; Karl Schaller; Eirik Helseth; Torstein R Meling
Journal: Neurosurg Rev Date: 2019-06-10 Impact factor: 3.042

3. Prognostic Value of Histopathological Features and Loss of H3K27me3 Immunolabeling in Anaplastic Meningioma: A Multicenter Retrospective Study.

Authors: Guillaume Gauchotte; Matthieu Peyre; Celso Pouget; Dominique Cazals-Hatem; Marc Polivka; Fabien Rech; Pascale Varlet; Hugues Loiseau; Stéphanie Lacomme; Karima Mokhtari; Michel Kalamarides; Franck Bielle
Journal: J Neuropathol Exp Neurol Date: 2020-05-24 Impact factor: 3.685

Why we need new classification models in meningioma management.

1. Pyrosequencing Analysis of MGMT Promoter Methylation in Meningioma.

2. WHO grade I meningiomas: classification-tree for prognostic factors of survival.

3. Prognostic Value of Histopathological Features and Loss of H3K27me3 Immunolabeling in Anaplastic Meningioma: A Multicenter Retrospective Study.

4. Surgery for convexity meningioma: Simpson Grade I resection as the goal: clinical article.

5. The recurrence of intracranial meningiomas after surgical treatment.

6. Meningioma Surgery-Are We Making Progress?

7. Prognostic Value of Ki-67/MIB-1 Expression in Meningioma Patients: A Meta-Analysis.

8. Histological transformation in recurrent WHO grade I meningiomas.

9. Extent of Resection in Meningioma: Predictive Factors and Clinical Implications.

10. Benefits of re-do surgery for recurrent intracranial meningiomas.

Review 1. Management of Recurrent Meningiomas: State of the Art and Perspectives.